Specify a stock or a cryptocurrency in the search bar to get a summary
Generation Bio Co
GBIOGeneration Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. Address: 301 Binney Street, Cambridge, MA, United States, 02142
Analytics
WallStreet Target Price
8.25 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures GBIO
Dividend Analytics GBIO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History GBIO
Stock Valuation GBIO
Financials GBIO
Results | 2019 | Dynamics |